Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
The first ever genetically modified porcine-to-human cardiac xenotransplant, providing new insight into a novel and evolving field. The first ever genetically modified porcine-to-human cardiac ...
PH is a progressive, life-threatening pulmonary vascular disease estimated to affect up to 1% of the global population. 1 It is often difficult to diagnose 2 due to non-specific early symptoms, such ...
The MarketWatch News Department was not involved in the creation of this content. -- Marks HeartBeam's transition to commercial company -- Rapidly growing practice and highly engaged member population ...
The 32-bit ColdFire microcontroller from Freescale can be incorporated with ECG software from Monebo. Driven by increasing incidences of diabetes and cardiovascular illnesses, home-monitoring, ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today that ...
BELFAST, Northern Ireland--(BUSINESS WIRE)--B-Secur today launched an ECG hardware and software development kit which can help technology companies fast-track the development of their ECG devices.
Marks HeartBeam’s transition to commercial company Rapidly growing practice and highly engaged member population to enable broad adoption Enables efficient scaling of additional preventive cardiology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results